ATE366807T1 - Fehlpaarungsendonukleasen und verwendungsverfahren - Google Patents

Fehlpaarungsendonukleasen und verwendungsverfahren

Info

Publication number
ATE366807T1
ATE366807T1 AT03706015T AT03706015T ATE366807T1 AT E366807 T1 ATE366807 T1 AT E366807T1 AT 03706015 T AT03706015 T AT 03706015T AT 03706015 T AT03706015 T AT 03706015T AT E366807 T1 ATE366807 T1 AT E366807T1
Authority
AT
Austria
Prior art keywords
heteroduplex
complementarity
polynucleotide
mismatches
increased
Prior art date
Application number
AT03706015T
Other languages
English (en)
Inventor
Hal Padgett
Andrew Vaewhongs
Fakhrieh Vojdani
Mark Smith
John Lindbo
Wayne Fitzmaurice
Original Assignee
Large Scale Biology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/098,155 external-priority patent/US20030157495A1/en
Application filed by Large Scale Biology Corp filed Critical Large Scale Biology Corp
Application granted granted Critical
Publication of ATE366807T1 publication Critical patent/ATE366807T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C12N15/1027—Mutagenizing nucleic acids by DNA shuffling, e.g. RSR, STEP, RPR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
    • C12N15/8203—Virus mediated transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AT03706015T 2002-02-01 2003-01-31 Fehlpaarungsendonukleasen und verwendungsverfahren ATE366807T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35372202P 2002-02-01 2002-02-01
US10/098,155 US20030157495A1 (en) 2002-02-01 2002-03-14 Nucleic acid molecules encoding CEL I endonuclease and methods of use thereof
US10/211,079 US7078211B2 (en) 2002-02-01 2002-08-01 Nucleic acid molecules encoding endonucleases and methods of use thereof

Publications (1)

Publication Number Publication Date
ATE366807T1 true ATE366807T1 (de) 2007-08-15

Family

ID=27739010

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03706015T ATE366807T1 (de) 2002-02-01 2003-01-31 Fehlpaarungsendonukleasen und verwendungsverfahren

Country Status (8)

Country Link
US (4) US7078211B2 (de)
EP (1) EP1565557B1 (de)
JP (1) JP4395632B2 (de)
AT (1) ATE366807T1 (de)
AU (1) AU2003207776B2 (de)
CA (1) CA2473187C (de)
DE (1) DE60314902T2 (de)
WO (1) WO2003066809A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7838219B2 (en) * 2001-02-02 2010-11-23 Novici Biotech Llc Method of increasing complementarity in a heteroduplex
US20110111413A1 (en) * 2001-02-02 2011-05-12 Padgett Hal S Method of optimizing codon usage through dna shuffling
US20020146732A1 (en) * 2001-02-02 2002-10-10 Padgett Hal S. Method of increasing complementarity in a heteroduplex
US7078211B2 (en) * 2002-02-01 2006-07-18 Large Scale Biology Corporation Nucleic acid molecules encoding endonucleases and methods of use thereof
EP1574570A1 (de) * 2004-03-12 2005-09-14 Universität Regensburg Verfahren zur Verringerung der Anzahl von fehlgepaarten Nukleotiden in doppelsträngigen Polynukleotiden
ES2292270B1 (es) * 2004-04-14 2009-02-16 Oryzon Genomics, S.A. Procedimiento para detectar selectivamente acidos nucleicos con estructuras atipicas convertibles en muescas.
US20060029612A1 (en) * 2004-04-15 2006-02-09 Large Scale Biology Corporation Prevention and treatment of recurrent respiratory papillomatosis
US7729761B2 (en) * 2004-07-14 2010-06-01 Cardiac Pacemakers, Inc. Method and apparatus for controlled gene or protein delivery
EP1771555B1 (de) * 2004-07-30 2011-01-12 Genoplante-Valor Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung
KR20080038131A (ko) * 2005-07-18 2008-05-02 프로탈릭스 리미티드 생물학적으로 활성인 거대분자의 점막 또는 장관 투여
WO2007038145A2 (en) * 2005-09-08 2007-04-05 Large Scale Biology Corporation Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications
WO2007101028A2 (en) * 2006-02-24 2007-09-07 Transgenomic, Inc. Method to produce enzymatically active recombinant endonucleases
US7888475B2 (en) * 2008-09-15 2011-02-15 Padgett Hal S Interferon alpha and interferon kappa fusion protein
WO2011102802A1 (en) * 2010-02-18 2011-08-25 Agency For Science, Technology And Research Method for reducing mismatches in double-stranded dna molecules
CN107058059B (zh) 2011-09-26 2020-08-07 基因技术股份公司 高效的小体积核酸合成
EP2809795B1 (de) 2012-02-01 2019-09-18 SGI-DNA, Inc. Materialien und verfahren zur synthese von fehlerminimierten nucleinsäuremolekülen
US20130274129A1 (en) 2012-04-04 2013-10-17 Geneart Ag Tal-effector assembly platform, customized services, kits and assays
US10563240B2 (en) 2013-03-14 2020-02-18 Life Technologies Corporation High efficiency, small volume nucleic acid synthesis
US20150119260A1 (en) * 2013-10-18 2015-04-30 National Taiwan University Circulating cancer biomarker and its use
WO2016011174A1 (en) 2014-07-15 2016-01-21 Life Technologies Corporation Compositions and methods for nucleic acid assembly
CN107532129B (zh) 2014-12-09 2022-09-13 生命技术公司 高效小体积核酸合成
WO2017007925A1 (en) 2015-07-07 2017-01-12 Thermo Fisher Scientific Geneart Gmbh Enzymatic synthesis of nucleic acid sequences
EP3763818A1 (de) 2015-10-06 2021-01-13 Pierce Biotechnology, Inc. Vorrichtungen und verfahren zur herstellung von proteinen
WO2017125893A1 (en) * 2016-01-22 2017-07-27 Vyome Biosciences Pvt. Ltd. Method of detecting and treating p. acnes and kit thereof
US20210147830A1 (en) 2018-06-29 2021-05-20 Thermo Fisher Scientific Geneart Gmbh High throughput assembly of nucleic acid molecules
GB201905303D0 (en) 2019-04-15 2019-05-29 Thermo Fisher Scient Geneart Gmbh Multiplex assembly of nucleic acid molecules
EP4114972A1 (de) 2020-03-06 2023-01-11 Life Technologies Corporation Nukleinsäuresynthese und -anordnung mit hoher sequenztreue
EP4095254A3 (de) 2021-05-27 2022-12-14 New England Biolabs, Inc. Fragmentierung von dna

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US45175A (en) * 1864-11-22 Improved grinding-plate
US48268A (en) * 1865-06-20 Improved process for preparing coffee
US17477A (en) * 1857-06-09 allerton
GB2183661B (en) * 1985-03-30 1989-06-28 Marc Ballivet Method for obtaining dna, rna, peptides, polypeptides or proteins by means of a dna recombinant technique
US4994368A (en) * 1987-07-23 1991-02-19 Syntex (U.S.A.) Inc. Amplification method for polynucleotide assays
US5459039A (en) * 1989-05-12 1995-10-17 Duke University Methods for mapping genetic mutations
US5556750A (en) * 1989-05-12 1996-09-17 Duke University Methods and kits for fractionating a population of DNA molecules based on the presence or absence of a base-pair mismatch utilizing mismatch repair systems
US5556747A (en) * 1990-07-09 1996-09-17 E. R. Squibb & Sons, Inc. Method for site-directed mutagenesis
US5795747A (en) * 1991-04-16 1998-08-18 Evotec Biosystems Gmbh Process for manufacturing new biopolymers
DE4112440C1 (de) 1991-04-16 1992-10-22 Diagen Institut Fuer Molekularbiologische Diagnostik Gmbh, 4000 Duesseldorf, De
AU3919293A (en) 1992-03-27 1993-11-08 University Of Maryland At Baltimore Detection of gene mutations with mismatch repair enzymes
US6165793A (en) * 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
EP0832210B1 (de) 1995-06-07 2004-10-27 Trevigen, Inc. Methode zur detektion von punktmutanten mittels nukleinsäurereperaturenzym und in vitro mutagenese
US6057103A (en) * 1995-07-18 2000-05-02 Diversa Corporation Screening for novel bioactivities
EP0870060B1 (de) * 1995-12-15 2003-04-02 Duke University Verfahren zum nachweis und zur entfernung von mutantsequenzen, die während enzymatischer amplifikation entstehen
US7115413B2 (en) 1996-04-01 2006-10-03 Mixis France S.A. Meiotic recombination in vivo of partially homologous DNA sequences
AU721493B2 (en) 1996-06-05 2000-07-06 Fox Chase Cancer Center Mismatch endonucleases and uses thereof in identifying mutations in targeted polynucleotide strands
US5869245A (en) * 1996-06-05 1999-02-09 Fox Chase Cancer Center Mismatch endonuclease and its use in identifying mutations in targeted polynucleotide strands
FR2772048B1 (fr) 1997-12-04 2001-12-21 Biomethodes Procede de clonage par digestion multiple, vecteurs pour sa mise en oeuvre et ses applications
AU746786B2 (en) 1997-12-08 2002-05-02 California Institute Of Technology Method for creating polynucleotide and polypeptide sequences
US6846655B1 (en) * 1998-06-29 2005-01-25 Phylos, Inc. Methods for generating highly diverse libraries
FR2789696A1 (fr) 1999-02-12 2000-08-18 Biomethodes Procede de mutagenese d'un fragment d'acide nucleique par clonage et polymerisation-ligation
FR2793807B1 (fr) 1999-05-20 2003-05-16 Biomethodes Methode d'insertion d'un fragment d'acide nucleique dans un vecteur, ses applications et les kits pour sa mise en oeuvre
DE19953854C2 (de) 1999-11-09 2002-01-17 Max Planck Gesellschaft Verfahren zur Herstellung von Biopolymeren mit veränderten Eigenschaften
JP4986358B2 (ja) 2000-02-22 2012-07-25 フォックス・チェイス・キャンサー・センター ミスマッチエンドヌクレアーゼをコードする核酸分子およびその使用方法
US6391557B1 (en) * 2000-02-22 2002-05-21 Fox Chase Cancer Center Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof
AU2001263411A1 (en) * 2000-05-23 2001-12-03 California Institute Of Technology Gene recombination and hybrid protein development
FR2813314B1 (fr) 2000-08-25 2004-05-07 Biomethodes Procede de mutagenese dirigee massive
CA2422749A1 (en) 2000-09-21 2002-03-28 Merck & Co., Inc. Method for generating recombinant polynucleotides
US6783941B2 (en) * 2000-12-06 2004-08-31 Novozymes A/S Method for producing a polynucleotide library in vitro by mismatch repair of heteroduplexes
US20020146732A1 (en) 2001-02-02 2002-10-10 Padgett Hal S. Method of increasing complementarity in a heteroduplex
US7078211B2 (en) * 2002-02-01 2006-07-18 Large Scale Biology Corporation Nucleic acid molecules encoding endonucleases and methods of use thereof
DE10248258A1 (de) 2002-10-16 2004-05-06 Biopsytec Analytik Gmbh Mutierte Nukleinsäure einer Cel I-Endonuklease und Verfahren zur Herstellung des rekombinanten vollständigen Cel I-Proteins

Also Published As

Publication number Publication date
CA2473187A1 (en) 2003-08-14
DE60314902T2 (de) 2008-04-10
US7078211B2 (en) 2006-07-18
EP1565557B1 (de) 2007-07-11
CA2473187C (en) 2012-07-31
EP1565557A4 (de) 2005-11-30
AU2003207776B2 (en) 2008-12-11
US20060194288A1 (en) 2006-08-31
US20030157682A1 (en) 2003-08-21
EP1565557A2 (de) 2005-08-24
AU2003207776A1 (en) 2003-09-02
US20030148315A1 (en) 2003-08-07
JP2005529586A (ja) 2005-10-06
US20080145913A1 (en) 2008-06-19
US7273739B2 (en) 2007-09-25
JP4395632B2 (ja) 2010-01-13
DE60314902D1 (de) 2007-08-23
WO2003066809A2 (en) 2003-08-14
WO2003066809A3 (en) 2005-06-30
US7056740B2 (en) 2006-06-06

Similar Documents

Publication Publication Date Title
ATE366807T1 (de) Fehlpaarungsendonukleasen und verwendungsverfahren
DE60234159D1 (de) Methode zur erhöhung der komplementarität in einem heteroduplex-polynucleotid
WO2002026727A3 (en) Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai
DK1929012T3 (da) Fremgangsmåde til in vitro-rekombination
EP1546174A4 (de) Verfahren und zusammensetzungen für rna-interferenz
WO2008083204A3 (en) Modulation of neurogenesis by melatoninergic ligands
PL414814A1 (pl) Oligonukleotyd immunostymulujący oraz kompozycja zawierająca taki oligonukleotyd do zastosowania w stymulowaniu odpowiedzi immunologicznej
ATE407138T1 (de) Verfahren zur herstellung interferierender rna- moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
WO2002098210A3 (en) Chromosome doubling method
NZ521698A (en) Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
NO20054343L (no) Behandling av immunologiske lidelser ved anvendelse av agonister av interleukin-21/interleukin-21 reseptor
HK1080122A1 (en) Coloured diamond
WO2005061734A3 (en) Double stranded linear nucleic acid probe and uses thereof
WO2005069893A3 (en) Catalyst and method for its manufacture
TW200518755A (en) Selective erbB2 inhibitor/anti-erbB antibody combinations in the treatment of cancer
NO20050716L (no) Enzymatisk pressfiltehandling
WO2004101889A3 (en) Use of hemicellulase composition in mechanical pulp production
MXPA04009380A (es) Sistema y metodo para la construccion de un proceso de administracion de proyectos.
EP1752534A4 (de) Hochgeschwindigkeits-pcr unter verwendung von hochgeschwindigkeits-dna-polymerase
HK1059439A1 (en) Compounds having activity as inhibitors of cytochrome p450rai
DE602005022490D1 (de) Mikroorganismus einer escherichia- oder corynebacterium-spezies mit einem fremdgen für nadp-abhängige glycerinaldehyd-3-phosphat-dehydrogenase und verfahren zur herstellung von l-lysin damit
NL1015129A1 (nl) Zeoliet IM-5 met fosfor, katalytische samenstelling, de bereiding en toepassing daarvan bij het katalytisch kraken.
WO2003088921A3 (en) Antisense modulation of hydroxysteroid 11-beta dehydrogenase 1 expression
WO2005052124A3 (en) Modified dna cleaving enzymes and methods of use
EP1648910A4 (de) Antisense-modulation der expression von stearoyl coa desaturase

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties